Institut Bordet - Retour à la page d'accueil
nl
Een gift voor onderzoek

François Sales

Dienst : Heelkunde
 
francois.sales [at] hubruxelles.be

Publicaties

Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.

Auteurs : Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F
Jaar : 2021
Journal : Mol Cancer Res

Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value.

Auteurs : Najem A, Wouters J, Krayem M, Rambow F, Sabbah M, Sales F, Awada A, Aerts S, Journe F, Marine JC, Ghanem GE
Jaar : 2021
Journal : Front Oncol

Recommendations for skin cancer consultation and surgery during COVID-19 pandemic.

Auteurs : Brochez L, Baurain JF, Del Marmol V, Nikkels A, Kruse V, Sales F, Stas M, Van Laethem A, Garmyn M
Jaar : 2020
Journal : J Eur Acad Dermatol Venereol

Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial.

Auteurs : Eggermont AMM, Rutkowski P, Dutriaux C, Hofman-Wellenhof R, Dziewulski P, Marples M, Grange F, Lok C, Pennachioli E, Robert C, Van Akkooi ACJ, Bastholt L, Minisini A, Marshall E, Sales F, Grob JJ, Bechter O, Schadendorf D, Marreaud S, Kicinski M, Suciu S, Testori AAE
Jaar : 2020
Journal : Eur J Cancer

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.

Auteurs : Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S, Sales F, Journe F, Awada A, Ghanem G, Van Gestel D
Jaar : 2019
Journal : Cancers (Basel)

Meer publicaties »